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Searching the protein sequence database for amino acid sequences homologous to the x-/or sequence inthe 
pX region of human T-c& leukemia virus types I and II (HTLV-I/II), we found that there is a region of 
38 amino acids where the murine interleukin 3 (IL-3) sequence has a 40% homology with the x-/or sequence. 
A statistica analysis shows that this homology is highly significant with a probability of 1.57 x lo-$4 The 
biological implication of this homology is discussed. 
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1. INTRODUCTION 2. METHODS AND RESULTS 
Human T-cell leukemia virus type I (HTLV-I) 
and type II (HTLV-II) are exogenous human 
retroviruses associated with certain diseases of T- 
cell malignancy [l-5]. In particular, HTLV-I is 
thought to be a causative agent for adult T-cell 
leukemia (ATL) [6,7]. One of the unique features 
of HTLVs that distinguish them from other 
chronic leukemia viruses is the presence of a 
unique gene called x-lor or tat in the pX region be- 
tween the env and 3 ‘-long terminal repeat (LTR) 
181. The x-for gene does not seem to be a typical 
cell-derived oncogene because DNA of the pX 
region does not hybridize significantly with normal 
human DNA [9]. Since the x-tar gene sequence has 
been conserved among HTLV-I [S], HTLV-II [IO], 
and even simian T-cell leukemia virus type I 
(STLV-I) [ 1 I], the x-/or gene product must mediate 
the neoplastic transformation of normal human T 
cells [12]. In fact, proteins of 41 and 38 kDa were 
found to be encoded from this region in HTLV-I- 
and HTLV-II-infected cells, respectively [13- 161. 
However, biological functions of the x-/or gene 
have not been identified. 
With the aim of elucidating the biologic func- 
tion of the x-lor gene, we searched for amino acid 
sequences homologous to the x-ior gene sequence 
in the NBRF protein sequence database f17]. In 
our computer search, we found that the murine in- 
terleukin 3 (IL-3) sequence [9,18-211 has a region 
of 38 amino acids where the x-/or gene products of 
HTLV-I/II and STLV-I have a 40% homology 
with the murine IL-3 (see fig.1). A statistical 
analysis shows that this homology is highly signifi- 
cant with a probability of 1.57 x lo-“. If the 
similarity between different amino acids is taken 
into account, the homology increases to a level of 
about 60% (see table 1). 
For this homologous region of 38 amino acids, 
we also compared the hydrophobicity profile and 
the predicted secondary structures for x-ior with 
those for the murine IL-3. As shown in fig.2, the 
overall patterns are very similar to each other. In 
particular, the hydrophobicity profiles of both se- 
quences exhibit four peaks roughly at the cor- 
responding sites. Moreover, the predicted 
secondary structures how that for both sequeilces 
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a-helix structures can be located at the N- and C- 
terminal sides in the homologous regions, though 
the possible positions of &structures for x-ior are 
slightly different from those for the murine IL-3. 
It is thus conceivable that murine IL-3 and x-lor 
possess similar secondary structures for the 
homologous region of 38 amino acids. 
IL-3 is one of a number of colony stimulating 
factors which are known to regulate 
haematopoiesis [ 181. The colony stimulating fac- 
tors are hormone-like glycoproteins which are 
biologically active at low .con~entrations. IL-3 is 
produced by mitogen or antigen-activated T cells, 
and it is involved in regulating the growth and dif- 
ferentiation of pluripotent stem cells leading to the 
production of all the major blood cell types [20]. 
It also has a broad range of biological activities 
and appears to be identical with a number of other 
factors named on the basis of their biological ac- 
tivities, such as multi-colony stimulating factor 
CSF, haematopoietic growth factor, mast cell 
growth factor and so forth [18]. 
Southern hybridization analysis using a probe 
derived from a mu~ne IL-3 cDNA clone revealed 
the presence of a single IL-3 gene in the haploid 
genome 1201. The murine IL-3 gene is made up of 
five exons interrupted by four introns [ 19,20]. The 
conserved region between the murine IL-3 and 
Table 1 
Homologies of amino acid sequences between the 
murine IL-3, and the region of 38 amino acids from the 
46th to the 83rd residues in the x-for of HTLV-I [8) and 
the corresponding regions of other viruses in the HTLV- 
I family 
IL-3 HTLV-I STLV-I HTLV-II BLVa 
IL-3 - 55% 58% 55% 31010 
(21) (22) (21) (11) 
HTLV-I 4O@!o - 92% 97% 53% 
(1% - (35) (371 (19) 
STLV-I 40% 89% - 89% 50% 
(15) (34) - (341 (18) 
HTLV-II 37qo 87% 76% - 58% 
(14) (33) (29) - (211 
BLV 17% 39% 36% 33qo - 
(61 (14) (13) (12) - 
a BLV has 36 amino acids, since the two gaps are 
necessary for the alignment with corresponding regions 
of other viruses in the HLTV-I family 1271 
The percentages in the lower-left domain represent 
homologies for identical amino acids only, whereas 
those in the upper-right represent homologies for similar 
amino acids. The values within parentheses how the 
number of identical amino acids 
‘IL-3 (74) RRVNLSKFVESQGEVDPEDRYVIKSNLQKLNCCLPTSA (111) 
* ++iCOQ+cS 
HTLV-I (46) ~HAL~ATC~~H~IT~~~I~GRV~~~~~QFL~~~~~~F~ ( 83) 
. 
STLV-I (46) ~~AL~~T,~~H~,T~~~T~ER~~~~~~~~~~PR~~~L~ ( 83) 
++ 8Q x 9s. 
HTLV-II (48) ~~~LEAT,~~H~LT~~~I~GR~~~~~~QYL~PRLP~F~ ( 8.5) 
#++ # t# # +## # #+ # ## # #,#t + 
.* 
BLV (42) ~ID~TLTCETHRIN~TA-DGR~~~L~-~T~~~~~HV~~ ( 77) 
# ++# + +# # 
Fig. 1. Alignment of the amino acid sequences between the murine IL-3 [18) and the x-/or regions of HTLV-I [8], STLV-I 
(1 I], HTLV-II [lo] and BLV [26] for the conserved region of 38 amino acids. * and : respectively represent amino acids 
of the HTLV-I family identical and similar to those of the murine IL-3. The probabilities that the obtained alignment 
with IL-3 occurs by chance are 1.57 x IO-", 1.57 x lo-“, 1.88 x 10e9, and 8.34 x 10e3 for HTLV-I, STLV-I, HTLV-II 
and BLV, respectively. # and + represent sites where all genes have identical and similar amino acids, respectively. 
The numbers in parentheses how residue numbers of starting and ending sites for the conserved region in a given x-lor 
sequence. 
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Fig.2. Hydrophobicity profiles and predicted secondary 
structures of the regions of 38 amino acids from the 46th 
to the 83rd residues of the x-for of HTLV-I (a) and the 
corresponding region (the 74th to the 11 ith residues) of 
the murine IL-3 (b). The hydrophobicity profiles were 
obtained by the method of Rose and Roy [37]. The 
ordinates represent free energy of transfer from aqueous 
to organic solvent. The secondary structures were 
predicted from conformational parameters of amino 
acids computed by Chou and Fasman [38,39]. Solid and 
open bars represent the possible regions of a-helix and 
p-structures, respectively. 
HTLVUII occupies almost entire domains of ex- 
ons 3 and 4. Analysis of a chemically synthesized 
protein of the murine IL-3 suggests that an amino 
terminal fragment of 79 amino acids in the mature 
murine IL-3 protein is sufficient to stimulate 
growth of IL-3-dependent cell lines [22]. In- 
terestingly, the conserved region is corresponding 
to the last 32 amino acids of the amino terminal 
fragment. Thus, this conserved region may have a 
function common to IL-3 and x-/or. 
Recently, the rat IL-3 gene sequence has also 
been determined 1231. Although the predicted 
amino acid sequences for the mature rat IL-3 
shows a relatively low homology (54%) with its 
murine counterpart, the rat IL-3 still retains an 
about 30% homology (and an about 50% 
homology for similar amino acids) with HTLV- 
I/II at the corresponding conserved region of the 
murine IL-3 with HTLV-I. However, Southern 
hybridization analysis of mammalian DNAs, using 
a murine IL-3 cDNA probe, fails to detect 
homologous sequences in most mammalian species 
including human (except rat), even under condi- 
tions for relatively low stringency 191. This ap- 
parent low conservation of mammalian IL-3 genes 
may be related to the fact that the sequence 
homologous to the pX region of HTLV-I is 
represented in the genomes of mouse and rat but 
not in other species including primates and human 
(91. This suggests that a part of the pX sequence 
may have derived from the rodent gene [9]. Since 
HTLV-I can infect primates, rabbit and rat, 
HTLV-I might have been prevalent among a wide 
variety of mammals and exchanged genetic 
segments (zoonotic) like influenza virus [9]. If the 
original host of HTLV-I is a rodent rather than 
man, the x-/or sequence should be homologous to 
host cellular sequences uch as the rodent IL-3 
genes and it can be reminiscent of the v-one gene. 
Our finding that the x-/or gene has a significant 
homology with the rodent IL-3 gene is also consis- 
tent with the folIowing facts. To date, various T- 
celI lines established by HTLV-induced transfor- 
mation have been demonstrated to produce several 
lymphokines including IL-3 [24,25]. This suggests 
that HTLV-I-induced transformation of T cells 
could induce the production of various lym- 
phokines and that the transformed cells retain their 
stable gene expression. Moreover, Ymer et al. [26] 
have reported that the constitutive synthesis of 
IL-3 by the murine myelomonoc~ic leukemia cell 
line, WEHI3B, is due to the insertion of an en- 
dogenous retrovirus-like element close to the 
5’-end of the IL-3 gene. It is possible that the ac- 
tivation of the IL-3 gene may have been an impor- 
tant step in the production of this leukemia [26]. 
Thus, biological functions of the pX gene involved 
in the mechanism of HTLV-induced leukemo- 
genesis may be related to those of IL-3. 
Bovine leukemia virus (BLV) also possesses a 
potential transforming gene, XBL, between the eplv 
gene and 3 ’ -LTR 1271. The amino acid sequence of 
the Xar_ gene of BLV is known to be homologous 
to that of HTLV-I only for the N-terminal region 
of about 80 amino acids 127,281. The homologous 
region of the murine IL-3 with HTLV-I/II cor- 
responds exactly to the last 36 amino acids of the 
homologous region between HTLV-I and BLV, 
though the homology between the murine IL-3 and 
BLV is not high (see fig.1). This lower homology 
between the murine IL-3 and BLV may be con- 
nected with the fact that enzootic bovine ieukosis 
caused by BLV is mainly for B cells (not T cells) 
129,301. 
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An IL-2 autocrine hypothesis for ATL 
leukemogenesis was previously proposed on the 
basis of the observation that an HTLV-carrying 
cell line, HUT102, produces IL-2 [31]. However, 
the inadequacy of this hypothesis was 
demonstrated by the finding that the IL-2 gene was 
not transcribed in any other cell lines carrying 
HTLV-I [31,32]. In fact, we could not find any 
significant homology between the coding region of 
IL-2 and the x-/or of HTLV-I/II. In contrast, it is 
suggested that IL-2 receptor (IL-2R) expression by 
ATL leukemia cells cot&d be involved in the 
mechanism of their leukemogenesis, since 
Sugamura et al. [33] obtained direct evidence for 
the IL-2R-inducing ability of HTLV-I. Recently, 
Birchenail-Sparks et al. [34] found that expression 
of the IL-2 receptor gene in hematopoietic ells can 
be regulated by IL-3. Thus, our findings are con- 
sistent with those observations. However, the x-/or 
gene products in all of HTLV-I/II are localized 
mostly in the nucleus of an infected cell [35]. Since 
the IL-3 protein may be secreted to the outside of 
the T cells, whether the x-/or gene has exactly the 
same function as the IL-3 gene remains to be 
solved. 
Recent evidence for a direct role of x-lor in 
trans-acting transcriptional regulation was provid- 
ed by the experiment of transcriptional activation 
of an LTR-linked CAT gene in cells transfected 
with only the x-lor gene [36]. Thus, it has been 
speculated that the x-lor gene product not only ac- 
tivates transcription of viral genes, but also 
positively or negatively regulates transcription of 
some cellular genes [12]. Activation of these genes 
on virus infection would then lead to immortaIiza- 
tion and subsequently transformation of these 
cells. This mechanism of Ieukemogenesis may be 
similar to the mechanism of T-cell activation by 
growth factors. However, the biological implica- 
tion of the homology between the murine IL-3 and 
x-lor should be examined experimentally. We hope 
that our finding can facilitate many experimen- 
talists to pay attention to IL-3 for elucidation of 
molecular mechanism of leukemogenesis. 
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